These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20223192)

  • 1. An alternative temperature-based histamine-sensitisation test for absence of residual pertussis toxin in acellular pertussis vaccines.
    Jensen SE; Engelhart Illigen KE; Hasløv KR
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):73-4. PubMed ID: 20223192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
    Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calibration of pertussis toxin BRP batch 1 in a standardised CHO cell-based clustering assay.
    Markey K; Douglas-Bardsley A; Hockley J; Le Tallec D; Costanzo A
    Pharmeur Bio Sci Notes; 2018; 2018():112-123. PubMed ID: 30272557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly sensitive histamine-sensitization test for residual activity of pertussis toxin in acellular pertussis vaccine.
    Ochiai M; Yamamoto A; Kataoka M; Toyoizumi H; Arakawa Y; Horiuchi Y
    Biologicals; 2007 Oct; 35(4):259-64. PubMed ID: 17363269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved protocols for histamine sensitization testing of acellular pertussis vaccines.
    Oh H; Joung J; Kim BG; Nam KT; Hong SH; Song HC; Lee HL; Ahn BY
    Vaccine; 2012 Nov; 30(50):7246-52. PubMed ID: 23084771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity and detection limit of a dermal temperature histamine sensitization test for absence of residual pertussis toxin in vaccines.
    Jensen SE; Illigen KE; Badsberg JH; Hasløv KR
    Biologicals; 2012 Jan; 40(1):36-40. PubMed ID: 22000164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADP-ribosylation activity in pertussis vaccines and its relationship to the in vivo histamine-sensitisation test.
    Gomez SR; Yuen CT; Asokanathan C; Douglas-Bardsley A; Corbel MJ; Coote JG; Parton R; Xing DK
    Vaccine; 2007 Apr; 25(17):3311-8. PubMed ID: 17287049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transferability study of CHO cell clustering assays for monitoring of pertussis toxin activity in acellular pertussis vaccines.
    Isbrucker R; Daas A; Wagner L; Costanzo A
    Pharmeur Bio Sci Notes; 2016; 2015():97-114. PubMed ID: 27506252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments in reduction and replacement of in vivo toxicity and potency tests for pertussis vaccines.
    Xing D; Canthaboo C; Douglas-Bardsley A; Yuen CT; Prior S; Liu Y; Corbel M
    Dev Biol (Basel); 2002; 111():57-68. PubMed ID: 12678225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Workshop on Animal free Detection of Pertussis Toxin in Vaccines--Alternatives to the Histamine Sensitisation Test.
    Bache C; Hoonakker M; Hendriksen C; Buchheit KH; Spreitzer I; Montag T
    Biologicals; 2012 Jul; 40(4):309-11. PubMed ID: 22609106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key points for the development of mouse immunogenicity test as potency assay for acellular pertussis vaccines.
    André M; Poirier B; Bornstein N; Marmonier D; El Zaouk A; Fuchs F
    Biologicals; 2000 Dec; 28(4):217-25. PubMed ID: 11237357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WHO working group on standardisation and control of acellular pertussis vaccines--report of a meeting held on 16-17 March 2006, St. Albans, United Kingdom.
    Xing DK; Corbel MJ; Dobbelaer R; Knezevic I
    Vaccine; 2007 Apr; 25(15):2749-57. PubMed ID: 17368348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards replacement of the acellular pertussis vaccine safety test: Comparison of in vitro cytotoxic activity and in vivo activity in mice.
    Wagner LD; Corvette LJ; Ngundi MM; Burns DL
    Vaccine; 2017 Dec; 35(51):7160-7165. PubMed ID: 29122386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An international collaborative study of the effect of active pertussis toxin on the modified Kendrick test for acellular pertussis vaccines.
    Xing D; Gaines Das R; Douglas-Bardsley A; Asokanathan C; Corbel M
    Biologicals; 2014 Mar; 42(2):101-8. PubMed ID: 24388289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis toxin-induced histamine sensitisation: an aspecific phenomenon independent from the nitric oxide system?
    van Meijeren CE; Vleeming W; van de Kuil T; Gerards AL; Hendriksen CF; de Wildt DJ
    Eur J Pharmacol; 2004 Jun; 493(1-3):139-50. PubMed ID: 15189775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cAMP assay: a functional in vitro alternative to the in vivo Histamine Sensitization test.
    Hoonakker ME; Ruiterkamp N; Hendriksen CF
    Vaccine; 2010 Feb; 28(5):1347-52. PubMed ID: 19941995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an in vitro assay system as a potential alternative to current histamine sensitization test for acellular pertussis vaccines.
    Xing D; Yuen CT; Asokanathan C; Rigsby P; Horiuchi Y
    Biologicals; 2012 Nov; 40(6):456-65. PubMed ID: 22890129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of residual pertussis toxin in vaccines using a modified ribosylation assay.
    Yuen CT; Canthaboo C; Menzies JA; Cyr T; Whitehouse LW; Jones C; Corbel MJ; Xing D
    Vaccine; 2002 Nov; 21(1-2):44-52. PubMed ID: 12443661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the carbohydrate binding and ADP-ribosyltransferase activities of chemically detoxified pertussis toxins.
    Oh H; Kim BG; Nam KT; Hong SH; Ahn DH; Choi GS; Kim H; Hong JT; Ahn BY
    Vaccine; 2013 Jun; 31(29):2988-93. PubMed ID: 23664992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.